Showing Results for
- Academic Journals (16)
Search Results
- 16
Academic Journals
- 16
-
From:PLoS ONE (Vol. 17, Issue 1) Peer-ReviewedFor long-term treatment of hepatitis B virus (HBV) infection, switching from tenofovir-disoproxil-fumarate (TDF) to tenofovir-alafenamide (TAF) may prevent renal dysfunction and bone loss. However, the precise effects of...
-
From:PLoS ONE (Vol. 16, Issue 3) Peer-ReviewedA deteriorated liver functional reserve during systemic therapy for unresectable hepatocellular carcinoma (HCC) causes poor patient outcomes. We aimed to identify predictive factors associated with the deterioration of...
-
From:PLoS ONE (Vol. 7, Issue 11) Peer-ReviewedAuthor(s): Daisuke Nishihara 1 , 3 , Ichiro Yajima 2 , Hiromasa Tabata 3 , Masato Nakai 3 , Nagaharu Tsukiji 1 , Tatsuya Katahira 4 , Kazuhisa Takeda 5 , Shigeki Shibahara 5 , Harukazu Nakamura 1 , 6 , Hiroaki Yamamoto...
-
From:Proceedings of the National Academy of Sciences of the United States (Vol. 96, Issue 7) Peer-ReviewedAbstract Only
-
From:PLoS ONE (Vol. 13, Issue 12) Peer-ReviewedAim We comprehensively analyzed how hepatitis C virus (HCV) eradication by interferon (IFN)-free direct-acting-antiviral-agents (DAAs) affects liver steatosis and atherogenic risk. Methods Patients treated with...
-
From:Proceedings of the National Academy of Sciences of the United States (Vol. 117, Issue 51) Peer-ReviewedAbstract Only